The estrogen receptor modulator tamoxifen enhances spontaneous glycinergic synaptic inhibition of hypoglossal motoneurons

Endocrinology

Volumn 146, Issue 10, 2005, Pages 4302-4311

  Chesnoy Marchais, D ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CALCIUM CHANNEL BLOCKING AGENT; GLYCINE; GLYCINE RECEPTOR; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TETRODOTOXIN;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; ELECTRIC CURRENT; FACILITATION; FEMALE; FREQUENCY MODULATION; HYPOGLOSSAL NERVE; MALE; MOTONEURON; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; RECORDING; SENSITIVITY ANALYSIS; SYNAPTIC INHIBITION; TISSUE SLICE; VOLTAGE CLAMP; WHOLE CELL;

ANIMALS; FEMALE; GLYCINE; HYPOGLOSSAL NERVE; MALE; MEMBRANE POTENTIALS; MOTOR NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; STRYCHNINE; SYNAPSES; TAMOXIFEN;

EID: 24944534445     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0453     Document Type: Article

References (57)

1. Schwartz J 2004 Tamoxifen: an emerging preventive. Front Biosci 9:2827-2847
2. Sugimoto Y, Tsukahara S, Imai Y, Sugimoto Y, Ueda K, Tsuruo T 2003 Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol Cancer Ther 2:105-112
3. Top S, Vessières A, Leclercq G, Quivy J, Tang J, Vaissermann J, Huché M, Jaouen G 2003 Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. Chem Eur J 9:5223-5236
4. Chesnoy-Marchais D 2003 Potentiation of glycine responses by dideoxyforskolin and tamoxifen in rat spinal neurons. Eur J Neurosci 17:681-691
5. Lien EA, Wester K, Lonning PE, Solheim E, Ueland PM 1991 Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. Br J Cancer 63:641-645
6. Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, Panella TJ, Jordan VC, Fine RL 1992 High-dose oral tamoxifen, a potential multidrugresistance-reversal agent: phase I trial in combination with vinblastine. J Natl Cancer Inst 84:1811-1816
7. Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ 2004 Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 21:364-371
8. Shy H, Malaiyandi L, Timiras PS 2000 Protective action of 17β-estradiol and tamoxifen on glutamate toxicity in glial cells. Int J Dev Neurosci 18:289-297
9. O'Neill K, Chen S, Diaz Brinton R 2004 Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Exp Neurol 188:268-278
10. Ciriza I, Carrero P, Azcoitia I, Lundeen SG, Garcia-Segura LM 2004 Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J Neurobiol 61:209-221
11. Kimelberg HK, Jin Y, Charniga C, Feustel PJ 2003 Neuroprotective activity of tamoxifen in permanent focal ischemia. J Neurosurg 99:138-142
12. Lynch JW 2004 Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84:1051-1095
13. Singer JH, Talley EM, Bayliss DA, Berger AJ 1998 Development of glycinergic synaptic transmission to rat brain stem motoneurons. J Neurophysiol 80:2608-2620
14. Suwa H, Saint-Amant L, Triller A, Drapeau P, Legendre P 2001 High-affinity zinc potentiation of inhibitory postsynaptic glycinergic currents in the zebrafish hindbrain. J Neurophysiol 85:912-925
15. 2 and postsynaptic glycine receptors. Eur J Neurosci 16:1025-1036
16. Yevenes GE, Peoples RW, Tapia JC, Parodi J, Soto X, Olate J, Aguayo LG 2003 Modulation of glycine-activated ion channel function by G-protein βγ sub-units. Nat Neurosci 6:819-824
17. Cheng G, Kendig JJ 2002 Pre- and postsynaptic volatile anaesthetic actions on glycinergic transmission to spinal cord motor neurons. Br J Pharmacol 136:673-684
18. Eggers ED, O'Brien JA, Berger AJ 2000 Developmental changes in the modulation of synaptic glycine receptors by ethanol. J Neurophysiol 84:2409-2416
19. - current by ethanol in cultured mouse spinal neurons. J Pharmacol Exp Ther 279:1116-1122
20. Ye JH, Tao L, Ren J, Schaefer R, Krnjevic K, Liu PL, Schiller DA, McArdle JJ 2001 Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area. J Pharmacol Exp Ther 296:77-83
21. Eggers ED, Berger AJ 2004 Mechanisms for the modulation of native glycine receptor channels by ethanol. J Neurophysiol 91:2685-2695
22. Sartor P, Vacher P, Mollard P, Dufy B 1988 Tamoxifen reduces calcium currents in a clonal pituitary cell line. Endocrinology 123:534-540
23. Song J, Standley PR, Zhang F, Joshi D, Gappy S, Sowers JR, Ram JL 1996 Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther 277:1444-1453
24. Chaban VV, Mayer EA, Ennes HS, Micevych PE 2003 Estradiol inhibits ATP-induced intracellular calcium concentration increase in dorsal root ganglia neurons. Neuroscience 118:941-948
25. Morley P, Whitfield JF 1994 Effect of tamoxifen on carbachol-triggered intracellular calcium responses in chicken granulosa cells. Cancer Res 54:69-74
26. Somjen D, Kohen F, Lieberherr M 1997 Nongenomic effects of an antiidiotypic antibody as an estrogen mimetic in female human and rat osteoblasts. J Cell Biochem 65:53-66
27. 2+ levels in human breast cancer cells. Breast Cancer Res Treat 71:125-131
28. Uchida S, Noda E, Kakazu Y, Mizoguchi Y, Akaike N, Nabekura J 2002 Allopregnanolone enhancement of GABAergic transmission in rat medial pre-optic area neurons. Am J Physiol Endocrinol Metab 283:E1257-E1265
29. Haage D, Johansson S 1999 Neurosteroid modulation of synaptic and GABAevoked currents in neurons from the rat medial preoptic nucleus. J Neurophysiol 82:143-151
30. - permeability in rat preoptic nerve terminals. Brain Res 958:405-413
31. Turecek R, Trussell LO 2001 Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse. Nature 411:587-590
32. Kawa K 2003 Glycine facilitates transmitter release at developing synapses: a patch clamp study from Purkinje neurons of the newborn rat. Brain Res Dev Brain Res 144:57-71
33. Jeong H-J, Jang I-S, Moorhouse AJ, Akaike N 2003 Activation of presynaptic glycine receptors facilitates glycine release from presynaptic terminals synapsing onto rat spinal sacral dorsal commissural nucleus neurons. J Physiol 550:373-383
34. Golding NL, Oertel D 1996 Context-dependent synaptic action of glycinergic and GABAergic inputs in the dorsal cochlear nucleus. J Neurosci 16:2208-2219
35. Chavas J, Marty A 2003 Coexistence of excitatory and inhibitory GABA synapses in the cerebellar interneuron network. J Neurosci 23:2019-2031
36. Marchetti C, Pagnotta S, Donato R, Nistri A 2002 Inhibition of spinal or hypoglossal motoneurons of the newborn rat by glycine or GABA. Eur J Neurosci 15:975-983
37. 2+ influx. J Neurosci 24:1226-1235
38. Toran-Allerand CD 2004 Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology 145:1069-1074
39. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
40. Thomas P, Pang Y, Filardo EJ, Dong J 2005 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624-632
41. Katsurabayashi S, Kubota H, Wang ZM, Rhee JS, Akaike N 2001 cAMP-dependent presynaptic regulation of spontaneous glycinergic IPSCs in mechanically dissociated rat spinal cord neurons. J Neurophysiol 85:332-340
42. Katsurabayashi S, Kubota H, Moorhouse AJ, Akaike N 2004 Differential modulation of evoked and spontaneous glycine release from rat spinal cord glycinergic terminals by the cyclic AMP/protein kinase A transduction cascade. J Neurochem 91:657-666
43. Umemiya M, Berger AJ 1995 Presynaptic inhibition by serotonin of glycinergic inhibitory synaptic currents in the rat brain stem. J Neurophysiol 73:1192-1201
44. Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK 2002 Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J Steroid Biochem Mol Biol 83:187-193
45. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ 2003 Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23:9529-9540
46. 1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780. Neuropharmacology 44:584-591
47. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB 1985 Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462-2465
48. 2+ sensor for vesicle fusion. Nature 435:497-501
49. Gundimeda U, Chen ZH, Gopalakrishna R 1996 Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 271:13504-13514
50. Ledoux VA, Woolley CS 2005 Evidence that disinhibition is associated with a decrease in number of vesicles available for release at inhibitory synapses. J Neurosci 25:971-976
51. Hardy SP, deFelipe C, Valverde MA 1998 Inhibition of voltage-gated cationic channels in rat embryonic hypothalamic neurones and C1300 neuroblastoma cells by triphenylethylene antioestrogens. FEBS Lett 434:236-240
52. Dick GM, Rossow CF, Smirnov S, Horowitz B, Sanders KM 2001 Tamoxifen activates smooth muscle BK channels through the regulatory β1 subunit. J Biol Chem 276:34594-34599
53. Dick GM, Sanders KM 2001 (Xeno)estrogen sensitivity of smooth muscle BK channels conferred by the regulatory β1 subunit: a study of β1 knockout mice. J Biol Chem 276:44835-44840
54. Green AR, Hainsworth AH, Jackson DM 2000 GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 39:1483-1494
55. Saransaari P, Oja SS 2000 Taurine and neural cell damage. Amino Acids 19:509-526
56. Feustel PJ, Jin Y, Kimelberg HK 2004 Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke 35:1164-1168
57. Allen NJ, Rossi DJ, Attwell D 2004 Sequential release of GABA by exocytosis and reversed uptake leads to neuronal swelling in simulated ischemia of hippocampal slices. J Neurosci 24:3837-3849